Stay updated on Abilify MyCite® in Schizophrenia 6-Month Clinical Trial
Sign up to get notified when there's something new on the Abilify MyCite® in Schizophrenia 6-Month Clinical Trial page.

Latest updates to the Abilify MyCite® in Schizophrenia 6-Month Clinical Trial page
- Check7 days agoChange DetectedSchizophrenia is added as a study condition. A Related Topics entry for MedlinePlus Genetics was added.SummaryDifference0.1%

- Check14 days agoChange DetectedThe 'Schizophrenia' topic and the related topic 'MedlinePlus Genetics' have been removed from the page's related topics/MeSH section. This update affects metadata rather than the core study details.SummaryDifference0.1%

- Check21 days agoChange DetectedPublications section wording now clarifies auto-population from PubMed; revision notes updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check28 days agoChange DetectedRemoved the government funding status notice; the primary study details and contact information remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check36 days agoChange DetectedAdded related topics 'Schizophrenia' and 'MedlinePlus Genetics' to the page. These metadata changes do not affect the study details or participation information.SummaryDifference0.1%

- Check43 days agoChange DetectedThe page no longer lists the study condition 'Schizophrenia' and removes the related topic 'MedlinePlus Genetics'.SummaryDifference0.4%

Stay in the know with updates to Abilify MyCite® in Schizophrenia 6-Month Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Abilify MyCite® in Schizophrenia 6-Month Clinical Trial page.